Screener
Regenxbio RGNX Issuance of stock under employee stock plans
Issuance of stock under employee stock plans at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans.
The source filing: Regenxbio’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-222804
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Cash flows from financing activities | ||
| Proceeds from exercise of stock options | 146 | 150 |
| Taxes paid related to net settlement of stock-based awards | (828) | (510) |
| Proceeds from issuance of common stock under employee stock purchase plan | 648 | 307 |
| Expenses related to at-the-market offering program | (230) | (147) |
| Repayments under royalty monetization liabilities, net of interest | (13,375) | (5,594) |
| Net cash used in financing activities | (13,639) | (5,794) |
| Net increase (decrease) in cash and cash equivalents and restricted cash | (19,237) | 72,578 |
Item 1. Financial Statements.
FAQ
- What is Regenxbio's issuance of stock under employee stock plans?
- Regenxbio (RGNX) reported issuance of stock under employee stock plans of $648K in Q1 2026.
- How has Regenxbio's issuance of stock under employee stock plans changed year-over-year?
- Regenxbio's issuance of stock under employee stock plans increased by 111.1% year-over-year, from $307K to $648K.
- What does issuance of stock under employee stock plans mean?
- Issuance of stock under employee stock plans
Ask your AI about Regenxbio's issuance of stock under employee stock plans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude